MLM
57
-3
ACN
70
5
VZ
42
3
XEL
65
-2
IFF
53
2
RRC
60
-3
KO
44
2
INTC
49
16
VNO
60
8
TRV
56
-2
QCOM
55
-2
DE
36
-2
JCI
61
-2
SLG
62
-4
FLS
76
-2
WFC
80
-2
NKE
33
2
FLR
48
3
CF
53
2
BA
45
-3
MLM
57
-3
ACN
70
5
VZ
42
3
XEL
65
-2
IFF
53
2
RRC
60
-3
KO
44
2
INTC
49
16
VNO
60
8
TRV
56
-2
QCOM
55
-2
DE
36
-2
JCI
61
-2
SLG
62
-4
FLS
76
-2
WFC
80
-2
NKE
33
2
FLR
48
3
CF
53
2
BA
45
-3
Financhill
Back

Dyne Therapeutics Stock Predictions

U.S. Government Report Alert Tuesday

Discover the Secret Loophole
Buy
66

DYN
Dyne Therapeutics

Last Price:
30.60
Seasonality Move:
38.02%

7 Day Trial

ALL ACCESS PASS

$ 7

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade

Dyne Therapeutics Stock Forecast

  • Over the next 52 weeks, Dyne Therapeutics has on average historically risen by 37.7% based on the past 4 years of stock performance.
  • Dyne Therapeutics has risen higher in 1 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%
  • Is Dyne Therapeutics Stock Undervalued?
    The current Dyne Therapeutics [DYN] share price is $34.14. The Score for DYN is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
  • DYN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Dyne Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Dyne Therapeutics has on average historically risen by 37.7% based on the past 4 years of stock performance.

Dyne Therapeutics Stock Rating

Buy
66
Dyne Therapeutics (DYN) is a Buy

Is Dyne Therapeutics overpriced?

  • Dyne Therapeutics has risen higher in 1 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%

Dyne Therapeutics Stock Price History

Is DYN stock going to rise?

  • The current trend is relatively stagnant and DYN is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
dyne-tx.com

52-Week Data

52-Week High:
47.45
52-Week Low:
9.26

Prediction Charts

Market Cap:
3.43B
Price in USD:
34.14
Volume:
2.22M
Beta:
1.09

Technical Analysis

SMA50:
32.62
SMA100:
37.04
SMA200:
32.06
52-Wk Change:
292.41%

Stock Predictions

  • Is Dyne Therapeutics stock public?
    Yes, Dyne Therapeutics is a publicly traded company.
  • What is the Dyne Therapeutics stock quote today?
    The Dyne Therapeutics stock price is 34.14 USD today.
  • How to buy Dyne Therapeutics stock online?
    You can buy Dyne Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-25 31.22 30.73 31.83 30.67
Oct-28 31.49 30.85 31.55 30.65
Oct-29 30.67 30.22 30.67 29.94
Oct-30 29.98 29.20 30.61 28.99
Oct-31 29.09 28.86 29.21 28.22
Nov-1 29.09 28.74 29.23 27.66
Nov-4 28.01 28.78 29.21 27.92
Nov-5 28.70 28.62 29.01 28.25
Nov-6 29.92 29.80 30.43 29.31
Nov-7 29.86 29.27 30.97 29.20
Nov-8 29.29 28.48 29.55 28.13
Nov-11 29.01 28.13 29.75 28.10
Nov-12 28.04 29.38 31.38 27.99
Nov-13 29.12 34.14 35.68 29.02

Dyne Therapeutics Earnings

Dyne Therapeutics Earnings Report: Per Share Dyne Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Dyne Therapeutics Forecast Revenue Growth

Dyne Therapeutics Stock Analysis: Historical quarterly revenues per share for Dyne Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.54 per share, and an increase next year of $0.08 per share.

* Dyne Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.